Chemotherapy side-effect management using mobile phones.
← Research streamA mobile-phone telemedicine system was developed for patients to complete symptom diaries that trigger nurse alerts for severe side-effects. Six patients used the system for two chemotherapy cycles; two cases of moderate symptoms deteriorating to more severe …
Study snapshot
Abstract
Colorectal cancer is a major health problem in developed countries, accounting for a significant proportion of deaths in the population. Advances in chemotherapy treatment have led to therapy being delivered in the home-setting, which presents challenges in ensuring that treatment-related side-effects are detected and reported to clinical staff in an appropriate time-frame. A telemedicine system has been developed using a mobile-phone platform to allow patients to complete symptom diaries which trigger alerts paged to their nurse in the event of severe side-effects. Six patients used this system for two cycles of oral chemotherapy. Two cases of moderate symptoms deteriorating to more severe conditions were observed, and individual self-care and treatment advice were presented to these patients.
AI evidence extraction
Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.
Main findings
A mobile-phone telemedicine system was developed for patients to complete symptom diaries that trigger nurse alerts for severe side-effects. Six patients used the system for two chemotherapy cycles; two cases of moderate symptoms deteriorating to more severe conditions were observed and advice was presented to these patients.
Outcomes measured
- Detection and reporting of chemotherapy side-effects
- Symptom diary completion
- Alerts to clinical staff (nurse paging)
- Self-care and treatment advice delivery
Limitations
- Very small sample size (six patients)
- No comparator/control group described
- Clinical outcomes and effectiveness metrics not quantified in the abstract
View raw extracted JSON
{
"study_type": "other",
"exposure": {
"band": null,
"source": "mobile phone",
"frequency_mhz": null,
"sar_wkg": null,
"duration": "two cycles of oral chemotherapy"
},
"population": "Patients receiving oral chemotherapy for colorectal cancer",
"sample_size": 6,
"outcomes": [
"Detection and reporting of chemotherapy side-effects",
"Symptom diary completion",
"Alerts to clinical staff (nurse paging)",
"Self-care and treatment advice delivery"
],
"main_findings": "A mobile-phone telemedicine system was developed for patients to complete symptom diaries that trigger nurse alerts for severe side-effects. Six patients used the system for two chemotherapy cycles; two cases of moderate symptoms deteriorating to more severe conditions were observed and advice was presented to these patients.",
"effect_direction": "unclear",
"limitations": [
"Very small sample size (six patients)",
"No comparator/control group described",
"Clinical outcomes and effectiveness metrics not quantified in the abstract"
],
"evidence_strength": "very_low",
"confidence": 0.74,
"peer_reviewed_likely": "yes",
"keywords": [
"colorectal cancer",
"chemotherapy",
"side-effect management",
"telemedicine",
"mobile phone",
"symptom diary",
"nurse alert",
"home-based care"
],
"suggested_hubs": []
}AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.
Identifiers and source
DOI: 10.1109/iembs.2008.4650374
PubMed: 19163877
Related papers
- 2.4 GHz Electromagnetic Field Influences the Response of the Circadian Oscillator in the Colorectal Cancer Cell Line DLD1 to miR-34a-Mediated Regulation 2022
- Novel Preoperative Cancer-Specific Glasgow Prognostic Score Strongly Predicts Survival in Stage II/III Colorectal Cancer. 2026
- Changes in miR-21, -138, -141, -135 expression and apoptosis/necrosis levels in HCT116 colon cancer cells under 50 Hz ELF-EMF exposure at 0.4 and 0.8 mT 2026
- Modified health effects of non-ionizing EMR combined with other agents reported in the biomedical literature 2017
- [Preliminary clinical comparison of HLF and ELF regimen in the treatment of advanced gastric carcinoma in middle-aged and elderly patients]. 2000
- Extremely low frequency electromagnetic fields prevent chemotherapy induced myelotoxicity. 2007